Omalizumab (Xolair) in Children Above 12 Years With Chronic Urticaria: A Review of Literature
Generally, 15-25% of general population experience urticaria during their life. The prevalence of chronic urticaria is about 0.1-0.3% in children and most often occurs between ages of 6-11 years. There are several causes for development of chronic urticaria. Known etiologies of chronic urticaria in...
Saved in:
Main Authors: | Javad Ghaffari (Author), Soheila Shahmohammadi (Author), Hossein Ashrafi (Author), Ali Reza Ranjbar (Author), Negar Ghaffari (Author) |
---|---|
Format: | Book |
Published: |
Mazandaran University of Medical Sciences,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omalizumab (Xolair) in Children Above 12 Years With Chronic Urticaria: A Review of Literature
by: Javad Ghaffari, et al.
Published: (2015) -
Omalizumab (Xolair) in Children with Atopic Dermatitis: A Review Article
by: Javad Ghaffari, et al.
Published: (2018) -
Omalizumab for treatment of chronic urticaria: A review of effective dose
by: javad Ghaffari, et al.
Published: (2019) -
Chronic urticaria in children: Etiologies, Clinical Manifestations, Diagnosis and Treatment
by: Javad Ghaffari, et al.
Published: (2013) -
Chronic urticaria in children: Etiologies, Clinical Manifestations, Diagnosis and Treatment
by: Javad Ghaffari, et al.
Published: (2013)